Mohammed Hasan Mukhtar
-
- Natural Antidiabetic Agents Studies 4
-
- Eosinophilic Esophagitis 3
- Helicobacter pylori-related gastroenterology studies 3
- Pancreatic function and diabetes 3
-
- COVID-19 Clinical Research Studies 4
-
- RNA Interference and Gene Delivery 3
- Metabolism, Diabetes, and Cancer 3
- Cell death mechanisms and regulation 2
Mohammed Hasan Mukhtar
30 papers receiving 527 citations
Peers
Comparison fields: 5 of 97
- Endocrinology, Diabetes and Metabolism 102
- Drug Discovery 1
- Nephrology 39
- Surgery 193
- Toxicology 13
Countries citing papers authored by Mohammed Hasan Mukhtar
This map shows the geographic impact of Mohammed Hasan Mukhtar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Hasan Mukhtar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Hasan Mukhtar more than expected).
Fields of papers citing papers by Mohammed Hasan Mukhtar
This network shows the impact of papers produced by Mohammed Hasan Mukhtar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Hasan Mukhtar. The network helps show where Mohammed Hasan Mukhtar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Hasan Mukhtar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 21 | |
| 9 | 2020 | 28 | |
| 10 | 2018 | 16 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 22 | |
| 13 | 2017 | 8 | |
| 14 | 2016 | 36 | |
| 15 | 2016 | 11 | |
| 16 | 2013 | 2 | |
| 17 | 2008 | 30 | |
| 18 | 2004 | 14 | |
| 19 | 2000 | 92 | |
| 20 | 1999 | 41 |
About Mohammed Hasan Mukhtar
Mohammed Hasan Mukhtar is a scholar working on Issues, ethics and legal aspects, Biochemistry and Clinical Biochemistry, having authored 33 papers that have together received 535 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Natural Antidiabetic Agents Studies (4 papers), Eosinophilic Esophagitis (3 papers), RNA Interference and Gene Delivery (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Pancreatic function and diabetes (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (102 citations), Drug Discovery (1 citation) and Nephrology (39 citations). Mohammed Hasan Mukhtar has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Loranne Agius, Wesam A. Nasif, Adel M. A. Assiri, Joan J. Guinovart, Joan Seoane, Núria de la Iglesia, Mark Stubbs, Sami S. Ashgar, Susan Aiston and Andrew Green. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.